Friederike Mumm

517 total citations
25 papers, 306 citations indexed

About

Friederike Mumm is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Friederike Mumm has authored 25 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 9 papers in Hematology. Recurrent topics in Friederike Mumm's work include Hematopoietic Stem Cell Transplantation (8 papers), Palliative Care and End-of-Life Issues (8 papers) and Cancer survivorship and care (7 papers). Friederike Mumm is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Palliative Care and End-of-Life Issues (8 papers) and Cancer survivorship and care (7 papers). Friederike Mumm collaborates with scholars based in Germany, Austria and United States. Friederike Mumm's co-authors include Pia Heußner, Katja Mehlis, Katsiaryna Laryionava, Wolfgang Hiddemann, Eva C. Winkler, Philipp Yorck Herzberg, Inken Hilgendorf, Daniel Wolff, Hildegard Greinix and Philipp Hemmati and has published in prestigious journals such as Blood, Frontiers in Psychology and Leukemia.

In The Last Decade

Friederike Mumm

19 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Friederike Mumm Germany	9	122	108	103	63	63	25	306
Rita Secola United States	11	91 0.7×	98 0.9×	87 0.8×	24 0.4×	107 1.7×	22	336
Micah Skeens United States	13	121 1.0×	81 0.8×	81 0.8×	38 0.6×	148 2.3×	57	476
Henrik Hjalgrim Denmark	11	56 0.5×	72 0.7×	58 0.6×	11 0.2×	57 0.9×	17	266
Aric Parnes United States	9	143 1.2×	86 0.8×	48 0.5×	29 0.5×	16 0.3×	30	320
Heather Tapp Australia	11	101 0.8×	101 0.9×	87 0.8×	11 0.2×	166 2.6×	27	407
Anne P.J. de Pagter Netherlands	10	73 0.6×	43 0.4×	18 0.2×	56 0.9×	37 0.6×	32	243
Evan Shereck United States	12	106 0.9×	56 0.5×	57 0.6×	27 0.4×	54 0.9×	25	303
Norsarwany Mohamad Malaysia	11	54 0.4×	61 0.6×	30 0.3×	24 0.4×	116 1.8×	34	398
Caroline E. Rouse United States	10	25 0.2×	83 0.8×	60 0.6×	22 0.3×	86 1.4×	23	324
Elizabeth Stenger United States	11	168 1.4×	57 0.5×	31 0.3×	47 0.7×	81 1.3×	37	470

Countries citing papers authored by Friederike Mumm

Since Specialization

Citations

This map shows the geographic impact of Friederike Mumm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Mumm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Mumm more than expected).

Fields of papers citing papers by Friederike Mumm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friederike Mumm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Mumm. The network helps show where Friederike Mumm may publish in the future.

Co-authorship network of co-authors of Friederike Mumm

This figure shows the co-authorship network connecting the top 25 collaborators of Friederike Mumm. A scholar is included among the top collaborators of Friederike Mumm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friederike Mumm. Friederike Mumm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Görlich, Dennis, Cristina Sauerland, Maja Rothenberg‐Thurley, et al.. (2025). Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia. Leukemia. 39(11). 2663–2672.

Mumm, Friederike, et al.. (2024). Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review. Cancer Medicine. 13(3). e6913–e6913. 7 indexed citations

Harbeck, Nadia, Hana Algül, Volker Heinemann, et al.. (2023). Stressors related to the COVID-19 pandemic and their association with distress, depressive, and anxiety symptoms in cancer out-patients. Frontiers in Psychology. 14. 1100236–1100236. 1 indexed citations

Harbeck, Nadia, Hana Algül, Volker Heinemann, et al.. (2022). Die Auswirkungen der COVID-19-Pandemie aus der Sicht ambulanter Krebspatienten. DMW - Deutsche Medizinische Wochenschrift. 147(10). 41–49. 2 indexed citations

Stock, Sophia, Julian Marcon, Michael Chaloupka, et al.. (2021). Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor. Case Reports in Oncology. 14(1). 681–689.

Erickson, Nicole, et al.. (2021). Patient-reported outcome measures obtained via E-Health tools ease the assessment burden and encourage patient participation in cancer care (PaCC Study). Supportive Care in Cancer. 29(12). 7715–7724. 8 indexed citations

Görlich, Dennis, Maja Rothenberg‐Thurley, Maria Cristina Sauerland, et al.. (2021). Quality of Life and Life Satisfaction in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study. Blood. 138(Supplement 1). 2289–2289.

Rothenberg‐Thurley, Maja, Maria Cristina Sauerland, Friederike Mumm, et al.. (2021). High Prevalence of CHF and Diabetes in AML Long-Term Survivors - a Patient Forever?. Blood. 138(Supplement 1). 4127–4127.

Mehlis, Katja, et al.. (2020). Late decisions about treatment limitation in patients with cancer: empirical analysis of end-of-life practices in a haematology and oncology unit at a German university hospital. ESMO Open. 5(5). e000950–e000950. 6 indexed citations

10.

Wolff, Daniel, Philipp Yorck Herzberg, Anne Herrmann, et al.. (2020). Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health. Bone Marrow Transplantation. 56(1). 243–256. 11 indexed citations

11.

Reinhard, Matthias A., Friederike Mumm, Claudia Bausewein, et al.. (2020). Psychosoziale Unterstützung während der COVID-19-Pandemie: interdisziplinäres Versorgungskonzept an einem Universitätsklinikum. Der Nervenarzt. 92(7). 701–707. 8 indexed citations

12.

Laryionava, Katsiaryna, Katja Mehlis, Friederike Mumm, et al.. (2018). Development and Evaluation of an Ethical Guideline for Decisions to Limit Life-Prolonging Treatment in Advanced Cancer: Protocol for a Monocentric Mixed-Method Interventional Study. JMIR Research Protocols. 7(6). e157–e157. 2 indexed citations

13.

Wolff, Daniel, Philipp Yorck Herzberg, Hildegard Greinix, et al.. (2017). Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial. Journal of Cancer Research and Clinical Oncology. 143(8). 1613–1619. 19 indexed citations

14.

Hubmann, Max, Susanne Fritsch, Dušan Prevalšek, et al.. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. Journal of Clinical Virology. 82. 33–40. 21 indexed citations

15.

Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2015). Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Annals of Hematology. 94(10). 1677–1688. 54 indexed citations

16.

Fritsch, Susanne, Dušan Prevalšek, Nicole Engel, et al.. (2015). Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation. 50(5). 679–684. 16 indexed citations

17.

Prevalšek, Dušan, Susanne Fritsch, Max Hubmann, et al.. (2015). Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced-Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High-Risk AML and MDS. Blood. 126(23). 4318–4318.

18.

Wolff, Daniel, Philipp Yorck Herzberg, Steven Z. Pavletic, et al.. (2013). Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial. Blood. 122(21). 2073–2073. 1 indexed citations

19.

Herzberg, Philipp Yorck, S J Lee, Pia Heußner, et al.. (2012). Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplantation. 48(1). 129–134. 20 indexed citations

20.

Herzberg, Philipp Yorck, Pia Heußner, Friederike Mumm, et al.. (2010). Validation of the Human Activity Profile Questionnaire in Patients after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(12). 1707–1717. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact